Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
Bilgin, Burak, endur, Mehmet AN, H zal, Mutlu, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent
Published in Future oncology (London, England) (01.09.2017)
Published in Future oncology (London, England) (01.09.2017)
Get full text
Journal Article
The current status of adjuvant treatment for high-risk renal cell carcinoma
H zal, Mutlu, endur, Mehmet AN, Bilgin, Burak, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent
Published in Future oncology (London, England) (01.10.2017)
Published in Future oncology (London, England) (01.10.2017)
Get full text
Journal Article
Do all aromatase inhibitors have similar efficacy and safety?
endur, Mehmet AN, Bilgin, Burak, H zal, Mutlu, Özdemir, Nuriye Y ld r m, Ak nc, Muhammed Bülent, Dede, Didem ener, Yalç n, Bulent
Published in Future oncology (London, England) (01.08.2017)
Published in Future oncology (London, England) (01.08.2017)
Get full text
Journal Article
Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer
endur, Mehmet AN, Bilgin, Burak, Ak nc, Muhammed B, Dede, Didem Sener, Özdemir, Nuriye, Ulas, Arife, Zengin, Nurullah, Yalç n, Bulent
Published in Future oncology (London, England) (01.02.2017)
Published in Future oncology (London, England) (01.02.2017)
Get full text
Journal Article
Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer
endur, Mehmet AN, Ak nc, Muhammed Bülent, Ozdemir, Nuriye Y ld r m, Aksoy, Sercan, Dede, Didem S, Ulas, Arife, Zengin, Nurullah, Yalç n, Bülent
Published in Future oncology (London, England) (01.04.2015)
Published in Future oncology (London, England) (01.04.2015)
Get full text
Journal Article